Statistics for Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Total visits

views
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial 4

Total visits per month

views
April 2025 0
May 2025 0
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0

File Visits

views
PIIS2352301822001631.pdf 19